Thyroid Cancer: Clinical Trials

3 trials for Thyroid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 recruiting. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Active not recruiting 1, Completed 1, Recruiting 1

Follow Thyroid Cancer: new trials by email Literature Review of Thyroid Cancer trials Research Report on Thyroid Cancer

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
INN805 - Maligant Solid Tumor, Head & Neck Cancer
Early Phase 1RecruitingFindCure Biosciences (ZhongShan) Co., Ltd.102026-04-202026-09-04
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Durvalumab (Medi4736), Radioiodine (RAI) - Thyroid Cancer
Early Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center112017-07-102026-08-11
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoid and Peroxisome-proliferator-activated Receptor (PPARy) Expression
Bexarotene - Thyroid Cancer
Early Phase 1CompletedUniversity of Colorado, Denver102008-11-012014-01-17

Narrower conditions

Thyroid Neoplasms (3)  ·  Aggression (1)  ·  Breast Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Sarcoma (1)

Broader conditions

Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Thyroid Diseases (3)  ·  Head and Neck Neoplasms (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Breast Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Social Behavior (1)

Interventions

Bexarotene (1)  ·  Iodine-131 (1)  ·  durvalumab (1)

Sponsors

FindCure Biosciences (ZhongShan) Co., Ltd. (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  University of Colorado, Denver (1)

Countries

United States (2)  ·  China (1)

Top investigators

Alan Ho, MD, PhD (1)  ·  Joshua Klopper, MD (1)